HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pagani, F. D. Articles by Bartlett, R. H. Search for Related Content PubMed PubMed Citation Articles by Pagani, F. D. Articles by Bartlett, R. H. Related Collections Congestive Heart Failure Mechanical Circulatory Assistance

Ann Thorac Surg 2001;71:S77-S81
© 2001 The Society of Thoracic Surgeons

---

Session 1: acute heart failure

The use of extracorporeal life support in adult patients with primary cardiac failure as a bridge to implantable left ventricular assist device

^a Section of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan, USA

Address reprint requests to Dr Pagani, Heart Transplant and Circulatory Assist Program, Section of Cardiac Surgery, University of Michigan, Taubman 2120, Box 0348, 1500 E Medical Center Dr, Ann Arbor, MI 48109
e-mail: fpagani{at}umich.edu

Presented at the Fifth International Conference on Circulatory Support Devices for Severe Cardiac Failure, New York, NY, Sept 15–17, 2000.

Abstract

Background. Extracorporeal life support (ECLS) is an effective technique for providing emergent circulatory assistance, and may represent a life-saving option in patients who might not initially be considered a candidate for other forms of circulatory support (extracorporeal or implantable left ventricular assist device [LVAD]). In the setting of cardiac arrest, ECLS represents the only viable method of initiating circulatory support. However, ECLS has a number of disadvantages that include high complication rates (eg, stroke, bleeding) and a limited duration of potential support, which have prevented its widespread acceptance, particularly in the adult population. With the increased successful application of long-term implantable LVADs as a bridge to transplant, the major limitation of ECLS could be overcome by bridging patients to a long-term implantable LVAD ("bridge to bridge"), thereby reducing the reluctance to utilize ECLS when indicated. After acquisition of the HeartMate LVAD (Thermo Cardiosystems, Inc, Woburn, MA) we investigated the use of ECLS as a bridge to an implantable LVAD and subsequent transplantation in selected high-risk patients.

Methods and Results. From Oct 1, 1996 to Sept 30, 2000, 33 adult patients presenting with cardiac arrest or severe hemodynamic instability were placed on ECLS for the bridge to bridge indication. Of the 33 patients, 10 patients survived to LVAD implant, 1 was bridged directly to transplant, 5 weaned from ECLS, and 16 died on ECLS. Overall, 12 patients survived to discharge. One-year actuarial survival from the initiation of ECLS was 36%. One-year actuarial survival from the time of LVAD implant, conditional on surviving ECLS, was 80%.

Conclusions. The 1-year survival of adult patients placed on ECLS and who subsequently survived to an implantable LVAD was favorable. These data support a strategy of ECLS to implantable LVAD bridge to heart transplant in adult patients who are in need of circulatory support and who are not initially candidates for other forms of mechanical support. The favorable results of this strategy support utilization of ECLS even in situations where myocardial recovery is thought to be unlikely.

This article has been cited by other articles:

				S. Schenk, L. Arusoglu, M. Morshuis, K. Minami, P. Sarnowski, R. Koerfer, and A. El-Banayosy Triple Bridge-to-Transplant in a Case of Giant Cell Myocarditis Complicated by Human Leukocyte Antigen Sensitization and Heparin-Induced Thrombocytopenia Type II. Ann. Thorac. Surg., March 1, 2006; 81(3): 1107 - 1109. [Abstract] [Full Text] [PDF]

				K. D. Reesink, L. D.C. Sauren, A. L.A.J. Dekker, E. Severdija, T. van der Nagel, G. G. Geskes, F. H. van der Veen, and J. G. Maessen Synchronously counterpulsating extracorporeal life support enhances myocardial working conditions regardless of systemic perfusion pressure Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 790 - 796. [Abstract] [Full Text] [PDF]

				Y. Asaumi, S. Yasuda, I. Morii, H. Kakuchi, Y. Otsuka, A. Kawamura, Y. Sasako, T. Nakatani, H. Nonogi, and S. Miyazaki Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation Eur. Heart J., October 2, 2005; 26(20): 2185 - 2192. [Abstract] [Full Text] [PDF]

				Y. Oishi, M. Masuda, K.-i. Imasaka, S. Morita, and H. Yasui Limitation of Venoarterial Bypass. Early Predictor and Optimal Conversion Asian Cardiovasc Thorac Ann, June 1, 2005; 13(2): 167 - 171. [Abstract] [Full Text] [PDF]

				M. P. Anstadt and J. E. Lowe Cardiopulmonary Resuscitation Card. Surg. Adult, January 1, 2003; 2(2003): 471 - 494. [Full Text]

				N. Moazami and P. M. McCarthy Temporary Circulatory Support Card. Surg. Adult, January 1, 2003; 2(2003): 495 - 520. [Full Text]